Biotech Business 180 Views Biosimilars: Opportunities & Challenges Ellen R. Delisio September 20, 2019 The development and use of …
Profiles in Pharma 370 Views Exclusive interview: Katarina Ageborg Ellen R. Delisio August 15, 2019 Few companies are as synonymous …
Drug development 5121 Views Stem cells in drug development Ellen R. Delisio May 31, 2019 The high cost and uncertain …
Norway 545 Views Politics Q&A: Iselin Nybø Ellen R. Delisio May 27, 2019 A nationwide initiative to increase …
Nobel Prize 197 Views James Allison – Nobel Laureate in Medicine Ellen R. Delisio May 17, 2019 When your passion and lifelong …
Profiles in Business 744 Views Gitte Aabo – A true pharmaceutical industry leader Ellen R. Delisio May 15, 2019 She joined LEO Pharma by …
Collaboration 276 Views Tromsø – An up-and-coming hub for biotech & health tech north of the Arctic Circle Ellen R. Delisio May 12, 2019 Long known for its natural …
Global report 1190 Views In focus – U.S. drug prices Ellen R. Delisio February 21, 2019 The stories have been in …
Digital Health 1647 Views AI in Nordic life sciences Ellen R. Delisio January 17, 2019 Artificial intelligence (AI) has taken …
Sweden 518 Views Life science efforts in Sweden Ellen R. Delisio December 19, 2018 Sweden is developing a new …
Collaboration 1564 Views Thinking outside the box in Umeå Ellen R. Delisio December 14, 2018 If any city could lay …
Profiles in Pharma 913 Views Exclusive R&D interview: David Fredrickson Ellen R. Delisio November 23, 2018 In an interview in Nordic …
Norway 1899 Views Medicine meets technology in Stavanger Ellen R. Delisio October 10, 2018 Norway’s Stavanger is a city …
Business article 1741 Views The Nordic Capital Landscape Ellen R. Delisio June 1, 2018 Life science and biotechnology companies …
Legal Advice article 867 Views Working as a life science lawyer Ellen R. Delisio May 15, 2018 Being part of a fast-paced …
Norway 2599 Views Oslo – Making its mark in cancer studies and multidisciplinary research Ellen R. Delisio May 15, 2018 For centuries, Oslo has been …
